ArticleBiologics : targets & therapy2026
Successful and Risk-Minimizing Treatment of Ulcerative Colitis by Positive Switch from JAK Inhibitors to Ustekinumab.
Haruka Otake et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
ArticleBiologics : targets & therapy2026
Haruka Otake et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.